jjs64, you're absolutely right: Buyer Beware before getting into
a non-reporting OTC-BB like OSCR... You're taking a risk and could lose your investment... On the other hand, if it pans out, you could do very well... I believe the 10SB is complete and should soon be filed, but that could be further delayed, as we all know...
I have researched this Company since Monday last week and have come to the conclusion that, considering what I know, it's worth the gamble... I have to believe they wouldn't be fool enough to report $20 Millions Net Profits Publicly (all PR's are part of a Company's Records) for the 3rd Quarter if it wasn't True. I also did speak personally to management to get a feel for its Truthfulness...
Now, even if this Company breaks even in the 1st, 2nd and 4th Quarters, the 3rd Quarter gives an EPS of $1.20. If you take a very conservative PE of 10, that still give you a share price of $12.00... So I concluded that the risk was reasonable enough to take, but this might not be the case for other investors.... Of course, I am a biased long... Potential investors should do extensive DD and only invest what they can afford to lose...
Regards, F. Goelo + + + |